Jan 2012

Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

International Journal for Parasitology: Drugs and Drug Resistance

by Freitas-Junior LH, Chatelain E, Kim HA, Siqueira-Neto JL. International Journal for Parasitology: Drugs and Drug Resistance, January 2012, Volume 2

Click here to read the article

Latest scientific articles

Stay connected

Get our latest news, personal stories, research articles, and job opportunities.

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

Latest scientific articles

Development and validation of ultra-performance liquid chromatography tandem mass spectrometry methods for the quantitative analysis of the antiparasitic drug DNDI-6148 in human plasma and various mouse biomatrices

Changes in lipid abundance are associated with disease progression and treatment response in chronic Trypanosoma cruzi infection

Climate change, migration, and health: perspectives from Latin America and the Caribbean

Immunotherapeutic strategies as potential treatment options for cutaneous leishmaniasis

Stay connected

Learn more

Get in touch

Support us

Work with us